Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience.
about
Strategy vaccination against Hepatitis B in ChinaHepatitis B vaccine by intradermal route in non responder patients: an update.A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.Effect of revaccination using different schemes among adults with low or undetectable anti-HBs titers after hepatitis B virus vaccinationHepatitis B vaccine in celiac disease: yesterday, today and tomorrow.Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.An economic assessment of pre-vaccination screening for hepatitis A and B.Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patientsImmunogenicity of Twinrix in older adults: a critical analysis.Polio vaccines and the cessation of vaccination.A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.The response of hepatitis B vaccination on seronegative adults with different vaccination schedules.Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults.Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination.Can HB vaccine yield a booster effect on individuals with positive serum anti-HBs and anti-HBc markers?A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing.Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults.Levamisole usage as an adjuvant to hepatitis B vaccine in hemodialysis patients, yes or no?New approaches in hepatitis B vaccination for celiac disease.Advances in therapeutics for chronic hepatitis B.The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience.Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.Cost-effectiveness of hepatitis A-B vaccine versus hepatitis B vaccine for healthcare and public safety workers in the western United States.Is a low dose of hepatitis B vaccine enough for a rapid vaccination scheme?Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility--Virginia, 2010.Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients.Unsolved problems and future perspectives of hepatitis B virus vaccination.The cost effectiveness of hepatitis immunization for US college students.Frequency of hepatitis B immunity and occupational exposures to body fluids among Brazilian medical students at a public university.Predictors of poor response after primary immunization of hepatitis B vaccines for infants and antibody seroprotection of booster in a metropolis of China.Seroconverting nonresponder of high-dose intramuscular HBV vaccine with intradermal HBV vaccine: A case report.Seroconvertion to hepatitis B vaccine after weight reduction in obese non-responder.Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults.Efficacy of Hepatitis B Vaccination among Children in Special Region of Yogyakarta, Indonesia: Evaluation of Humoral and Cellular Immunity.Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine.Travelers with underlying medical conditions
P2860
Q28081068-A7E52FC0-0CBE-47F4-B83B-A3B3B106017BQ34036643-B9D76151-0161-40D2-A869-A9489553F085Q34106036-44591D43-F972-4D70-A5E8-A79682EA0F8AQ34189953-6F18D8CB-7185-4862-BAF6-614C5770E911Q34329062-B6B9EC27-38AC-4EE6-B161-F987C3C9D3FEQ34621859-FE6D1849-5F57-4C14-8775-F277EE3D74A4Q34756504-BC48DF14-9DD2-46AB-993B-81D5266084E9Q34977127-88D888D5-23B4-46C7-A0E8-AF33ECDFB196Q35193521-4C2E2F03-2BE0-423E-BC6F-994D72756718Q35193552-AA61CF9C-3306-4B32-A844-F683262A8DBEQ35791752-110B6406-00E3-4FD5-92B8-F50623008DEFQ35887060-6F21BAD7-2CEA-4556-A49E-EB269A4DD600Q36177138-747FB56E-D85F-4BE0-B6CA-9EB2453EE36DQ36386300-EACF59E8-E87A-4361-AC94-7FC9C9A3FB57Q36474416-5C664DE5-646A-4F83-A0BD-5385AE118EEEQ36474454-30EBDDEB-336B-458A-A072-342BA1BEB005Q36711264-6C28E98A-FEFE-4D1A-BECA-E617A273F4A8Q37409653-443FB5F1-05F9-43BC-B9FC-A6A0726C0A18Q38098187-8F19052B-3A58-4407-8D29-99D730365E29Q38260053-1D0B3B7D-C851-49C3-BA5A-5A9A1A7AFC22Q38585657-DFF14686-A8AA-4F50-B999-3C12C5003711Q38675773-D91757A6-9628-4896-8F11-BD4DB2097488Q38721381-286947DC-70BC-4EF7-B642-A5CE6A3A3243Q40490586-8FC3E0A2-4A67-4AF3-8CAD-2A1E7444EA45Q41877137-BE80F07A-566D-4EF9-BF7C-04450CEB749EQ42235498-CA502FA1-B788-45A6-9E01-F12D0943A3AAQ42239771-9459C104-8CD6-478C-8208-BADD8D758707Q42412334-1D4BE085-C860-49F6-935A-558A7A288E77Q44864303-48B1CB44-AD27-4FC1-BE93-CBDE7105AA2EQ45254009-8A866481-520E-47E0-8C17-0D774F6558C8Q46056943-188E5CF9-AEC2-47B0-A62F-D069C04EBDAAQ47141419-28FB4B85-1743-4E58-90F4-E4B09D0A9306Q47233490-6DC1346B-FC8D-473B-A3E3-C1928243E59BQ49556817-F2C3E697-1501-459D-B1C0-2ACC62A35C6EQ50055700-97C6CD9B-371C-4EE8-8D4D-E1C4E1B083FAQ52730804-F2F36203-9BDE-4BC3-AEDB-B4C31520DABAQ57601485-807F5BE1-FECA-4EBC-BC48-E84CAE6DE858
P2860
Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Antibody-response to three rec ...... ravel-clinic based experience.
@en
Antibody-response to three rec ...... ravel-clinic based experience.
@nl
type
label
Antibody-response to three rec ...... ravel-clinic based experience.
@en
Antibody-response to three rec ...... ravel-clinic based experience.
@nl
prefLabel
Antibody-response to three rec ...... ravel-clinic based experience.
@en
Antibody-response to three rec ...... ravel-clinic based experience.
@nl
P2093
P1433
P1476
Antibody-response to three rec ...... ravel-clinic based experience.
@en
P2093
Holzmann H
Kollaritsch H
Rendi-Wagner P
Stemberger H
Wiedermann G
Wiesinger K
P304
P356
10.1016/S0264-410X(00)00410-2
P407
P577
2001-02-01T00:00:00Z